Clinical Trials Logo

Benign Masseteric Hypertrophy clinical trials

View clinical trials related to Benign Masseteric Hypertrophy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05964257 Recruiting - Clinical trials for Benign Masseteric Hypertrophy

To Evaluate the Efficacy and Safety of LIZTOX in Subjects With Benign Masseteric Hypertrophy

Start date: July 25, 2023
Phase: Phase 3
Study type: Interventional

A double-blind, randomized, placebo-controlled, multi-center, phase III study to evaluate the efficacy and safety of LIZTOX in subjects with benign massesric hypertrophy